Liver Fibrosis and Inflammation under the Control of ERK2

Liver Fibrosis and Inflammation under the Control of ERK2

Chronic liver injury could lead the formation of liver fibrosis, eventually some would develop to hepatocellular carcinoma (HCC), one of the leading malignancies worldwide. The aim of the study is to dissect the role of extracellular signal-regulated kinase 2 (ERK2) signaling in liver fibrosis and i...

Full description

Bibliographic Details
Main Authors:	Kuo-Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, Chiung-Fang Chang
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	ERK2 MAPK liver cirrhosis liver inflammation
Online Access:	https://www.mdpi.com/1422-0067/21/11/3796

Similar Items

Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways
by: Panpan Chen, et al.
Published: (2023-05-01)

Upper Gastrointestinal Cancer and Liver Cirrhosis
by: Kuo-Shyang Jeng, et al.
Published: (2022-05-01)

Saffron reduces the liver fibrosis in mice by inhibiting the JAK/STAT3 pathway
by: Lijuan Huang, et al.
Published: (2023-12-01)

Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches
by: Indu Rajapaksha
Published: (2022-11-01)

MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration
by: Xiaomin Wen, et al.
Published: (2022-01-01)

Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B
by: Jia D, et al.
Published: (2023-04-01)

A review of liver fibrosis and cirrhosis regression
by: Michael J. Lee
Published: (2023-07-01)

Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression
by: Magdalena Śmiech, et al.
Published: (2022-01-01)

Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma
by: Koya Yasukawa, et al.
Published: (2023-10-01)

Effect of albumin on indicators of systemic inflammation and endothelial dysfunction in patients with alcoholic liver cirrhosis in combination with obesity
by: N.H. Virstiuk, et al.
Published: (2020-09-01)

Reversal of liver fibrosis
by: Ismail Mona, et al.
Published: (2009-01-01)

Complex Cell Type-Specific Roles of Autophagy in Liver Fibrosis and Cirrhosis
by: Tzu-Min Hung, et al.
Published: (2020-03-01)

Involvement of the ERK MAPK Cascade in the Formation of Adhesions in the Abdominal Cavity
by: I. A. Shurygina, et al.
Published: (2021-01-01)

Blockade of the P2Y2 Receptor Attenuates Alcoholic Liver Inflammation by Targeting the EGFR-ERK1/2 Signaling Pathway
by: Liu ZN, et al.
Published: (2022-04-01)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
by: Li-ya Mu, et al.
Published: (2021-06-01)

Management Strategies for Liver Fibrosis
by: Alejandra Altamirano-Barrera, et al.
Published: (2017-01-01)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
by: Ya-Chun Chang, et al.
Published: (2022-03-01)

Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C
by: Thabata Glenda Fenili Amorim, et al.
Published: (2012-11-01)

Cirrhosis-Based Acute-on-Chronic Liver Failure Is Marked by Inflammation and Impaired Liver Regeneration Despite Stat3 Activation
by: Christian M. Lange, et al.
Published: (2022-01-01)

Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis
by: I V Kurbatova, et al.
Published: (2019-04-01)

Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
by: Lu Chen, et al.
Published: (2019-03-01)

Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension
by: Eric Kalo, et al.
Published: (2021-09-01)

Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
by: Tomoko Tadokoro, et al.
Published: (2021-07-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Diagnostic Accuracy of Indocyanine Green Clearance Test for Different Stages of Liver Fibrosis and Cirrhosis
by: Lukas Luerken, et al.
Published: (2023-08-01)

CHANGES IN FIBROSIS UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADEMETHYANINIUM AND ARGININE GLUTAMATE
by: N.R. Matkovska
Published: (2020-11-01)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
by: Isabel Graupera, et al.
Published: (2022-07-01)

Prognostic value of computed tomographic perfusion in the diagnosis of liver fibrosis and cirrhosis. Pilot study
by: G. A. Stashuk, et al.
Published: (2020-12-01)

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
by: Fu-Shun Yen, et al.
Published: (2022-02-01)

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study
by: Huang CH, et al.
Published: (2019-01-01)

Current Strategies for Quantitating Fibrosis in Liver Biopsy
by: Yan Wang, et al.
Published: (2015-01-01)

Paeoniflorin mitigates PBC-induced liver fibrosis by repressing NLRP3 formation
by: Yizhe Zhang, et al.
Published: (2022-02-01)

Histological evolution of fibrosis in patients with biliary atresia
by: Alexandre R. Ferreira, et al.
Published: (2019-11-01)

Diagnostic value of Transient Elastography (Fibroscan) in the evaluation of liver fibrosis in chronic viral hepatitis C: Comparison to liver biopsy
by: Mona El-Hariri, et al.
Published: (2017-06-01)

Improving the Effect of Ferulic Acid on Inflammation and Insulin Resistance by Regulating the JNK/ERK and NF-κB Pathways in TNF-α-Treated 3T3-L1 Adipocytes
by: Jae-Eun Park, et al.
Published: (2024-01-01)

Congenital Hepatic Fibrosis
by: MH Antikchi, et al.
Published: (2010-09-01)

Liver cirrhosis and pregnancy
by: Claudio Tiribelli, et al.
Published: (2006-07-01)

Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty LiverSummary
by: Raja Gopal Reddy Mooli, et al.
Published: (2021-01-01)

Thrombocytopenia (TCP), MELD Score, and Fibrosis Index (FI) Among Hospitalized Patients with Chronic Liver Disease (CLD) in Ma’abar City, Dhamar Governorate, Yemen: A Cross-Sectional Study
by: Al-Dholae MHH, et al.
Published: (2023-04-01)

Non Invasive Assessment of Fibrosis in Non Alcoholic Fatty Liver Disease by Shear Wave Elastography and NAFLD Fibrosis Score: A Cross-sectional Study
by: BN Vinyasa, et al.
Published: (2022-08-01)